Navigation Links
JCI online early table of contents: Sept. 1, 2010
Date:9/1/2010

ms of resistance might provide clues as to how to overcome this problem. A team of researchers, led by Steven de Jong, at the University of Groningen, The Netherlands, has now determined that high levels of expression of the protein p21 in the cytoplasm of tumor cells are a determinant of cisplatin-resistance in human testicular cancer cells known as testicular embryonal carcinoma cells. The team therefore suggests that targeting p21 in the cytoplasm might provide a way to treat testicular cancer that is resistant to platinum-based chemotherapeutics.

TITLE: Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer

AUTHOR CONTACT:
Steven de Jong
University Medical Center Groningen, Groningen, The Netherlands.
Phone: 31.0.50.3612964; Fax: 31.0.50.3614862; E-mail: s.de.jong@int.umcg.nl.

View this article at: http://www.jci.org/articles/view/41939?key=df301cc16f1792b9f7fa


METABOLIC DISEASE: Pacifying protein levels to treat diabetes

Individuals who have mutations in one of their two PDX1 genes are highly likely to develop diabetes. Understanding how levels of PDX1 are regulated is therefore of intense interest in the study and treatment of diabetes. A team of researchers, led by Doris Stoffers, at the University of Pennsylvania School of Medicine, Philadelphia, has now determined that the protein Pcif1 has a key role in regulating Pdx1 protein levels in mice. Specifically, Pcif1 was found to target Pdx1 for degradation. Interestingly, the signs of diabetes observed in mice lacking one Pdx1 gene were absent if one Pcif1 gene was also deleted, because Pdx1 protein levels became normalized. These data, which provide new insight into the regulation of Pdx1 protein levels, lead the authors to suggest that targeting PCIF1-mediated degradation o
'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
734-546-5242
Journal of Clinical Investigation
Source:Eurekalert

Page: 1 2 3 4 5 6

Related medicine news :

1. TheReliefPlace.com Launches Online Store “The Relief Shop” - What Does this Medical Supply Store Carry and How Can They Help You?
2. Web Content Management Enables Government Transparency, Participation, and Collaboration Online
3. DavisPTnetwork Partners with the New York Physical Therapy Association to Provide Online Continuing Education
4. PERSONALABS Offers Discounted Healthy Heart Online Blood Tests in February
5. Pharmahelper Pleased To Recognize Online Pharmacy Practice Standards Announced By Google Adwords
6. Online Dating Reinvents Itself with the Recent Roll-Out of Teacherhookup.com, a Free Website that Focuses on a Person's Career in Education!
7. EdenHome.com Adds Aventura Organic Clothes to Site and Announces Largest Online Selection of Stylish Organic Clothes for Men, Women and Children
8. Fire Protection Online Resolves Safety Concerns with CO2 Fire Extinguishers
9. JCI online early table of contents: Feb. 15, 2010
10. Fitness Trend Towards Online Personal Training Gets Real-World Weight Loss Results on FitOrbit.com
11. New Online Store Makes Buying Cosmetics a Healthy Choice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Mesa, Arizona (PRWEB) May 6, ... Ventures, Inc. (MAV), an investor backed Colorado cannabis ... based Phoenician Engineering subsidiary three times since first ... achieved profitability from operations, within one year of ... the end of 2014 to over 500 today ...
(Date:5/6/2015)... The American Water Resources Association (AWRA) announces ... Integrated Water Resources Management (IWRM) award , recognizing excellence in ... , An IWRM approach to water resources has been a ... 12 projects were nominated for the award. The May issue ... 2014 AWRA IWRM Award winner - One Water, One Watershed ...
(Date:5/6/2015)... NC (PRWEB) May 06, 2015 Doctors ... recently reported what they are calling “unprecedented” tumor control ... article on the new research. Click here to ... gave pembrolizumab to 25 mesothelioma patients between March and ... meeting in April. , “Pembrolizumab… provides robust antitumor activity ...
(Date:5/6/2015)... May 06, 2015 ProTrailer Cartoon Volume ... self-animating generators for Final Cut Pro X . ... titles to a Final Cut Pro X project.It includes ... quality openers to any shot has never been easier. ... in mind, saving users time while adding amazing openers ...
(Date:5/6/2015)... Omaha, NE (PRWEB) May 06, 2015 The ... to a nationwide nursing shortage to an increase in educational ... Aureus Medical Group , offers insight on these trends ... most of the multitude of opportunities that exist in the ... , Widespread electronic health record implementation has been prevalent across ...
Breaking Medicine News(10 mins):Health News:Cannibus Industry Start-Up Reaches Profitability While Expanding Its Proprietary Ancillary Medical Marijuana Product IP Portfolio 2Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:Researchers Say “Unprecedented” Mesothelioma Response Possible with Skin Cancer Drug, According to Surviving Mesothelioma 2Health News:Pixel Film Studios announces the release of Protrailer Cartoon Volume 2 for Final Cut Pro X. 2Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 2Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 3Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 4
... by Regulatory Approval of Once-Daily Tramadol in, ... for Depression -,LAVAL, QC, Feb. 26 /PRNewswire-FirstCall/ - Labopharm Inc. ... results for the fourth quarter and year ended December 31, ... , "With our first product about to be rolled out ...
... global rare disease community to raise awareness for underserved ... Feb. 26 Shire Human Genetic Therapies (HGT), a ... company, today announced it will join together with the ... Rare Disease Day on February 28, 2009. The purpose ...
... ST. LOUIS, Feb. 26 Stereotaxis, Inc.,(Nasdaq: ... fourth quarter,ended December 31, 2008. Revenue for the ... 18% over the fourth quarter of 2007. Stereotaxis,recognized ... systems in the quarter. Revenue from sales of ...
... 26 MIND Research Institute today,announced that Jim Mazzo, ... was recently elected to MIND,s board of directors. Mr.,Mazzo ... numerous boards and,committees at the University of California ... of Trustees, the Engineering Advisory Board Committee, and,the Eye ...
... Prestigious AwardsLONDON, Feb. 26 The Healthcare ... Frost & Sullivan,s ,Excellence in Healthcare Awards ... London Zoo, London. The industry,s most influential ... their achievements during an evening dinner gala.(Logo: ...
... Footwear by BeechHUNTINGTON BEACH, Calif., Feb. 26 ... Originals line with new adjustable toe separators ... foot therapy can now be customized to fit ... increasing flexibility and helping improve balance and body ...
Cached Medicine News:Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 2Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 3Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 4Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 5Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 6Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 7Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 8Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 9Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 10Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 11Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 12Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 13Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 14Health News:Shire Celebrates World Rare Disease Day on February 28 2Health News:Shire Celebrates World Rare Disease Day on February 28 3Health News:Shire Celebrates World Rare Disease Day on February 28 4Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 2Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 3Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 4Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 5Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 6Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 7Health News:Jim Mazzo Joins MIND Research Institute's Board of Directors 2Health News:Frost & Sullivan Awards to Celebrate Healthcare Excellence 2Health News:Sandal Evolution(R) Takes a Healthy Step 2
(Date:5/6/2015)...  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) ("Galmed"), ... commercialization of a once-daily, oral therapy for the treatment ... it will host a conference call and webcast on ... period ended March 31, 2015 and to provide an ... program for aramchol. Conference Call & ...
(Date:5/6/2015)... GERMANTOWN, Md. , May 6, 2015 ... neural stem cell technology to develop small molecule and ... the appointment of Jonathan Lloyd Jones to ... th . Mr. Lloyd Jones ... of corporate finance and business development experience.   Most recently, ...
(Date:5/6/2015)... 6, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ... for the three-month period ended March 31, 2015. First quarter ... million, an increase of 19% as compared to $7.0 ... Product revenues increased 41% year-over-year, enabled by the return ... Merck Serono in the fourth quarter of 2014; ...
Breaking Medicine Technology:Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 2Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 2Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 3Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 5Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 6Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 7Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 8Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 9Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 10Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 11
... 26, 2007,/PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. , ... announced that,the two-year data from its European ... ("Vascular Wrap(TM)"),will be presented today at a ... the safety and efficacy of the Vascular,Wrap(TM) ...
... cord and other central,nervous system transplants possible, BOSTON, ... Eye Research Institute, an affiliate of Harvard Medical,School, ... into the adult central nervous system. The,study found ... induced by,stem cells) has the ability to break ...
Cached Medicine Technology:Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 2Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 3Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 5Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 6Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 7Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 2Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 3
... surgeons with brighter, crisper, magnified views of ... many minimally invasive spine procedures. It is ... of contact. The first graphical touchscreen to ... intuitive user guidance similar to that known ...
Micro Dissecting Curette, 5 1/2", Round....
14 cm, very delicate, round cupped jaws, straight jaws, 3.0 mm...
Wilson pituitary forcep, flattened tip, 3 mm bite, 145 mm effective....
Medicine Products: